{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:59:20Z","timestamp":1777600760277,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702372"],"award-info":[{"award-number":["81702372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Natural Science Foundation of China","award":["18ZR1406800"],"award-info":[{"award-number":["18ZR1406800"]}]},{"name":"Xiamen Science and Technology Project of Fujian Province, China","award":["3502Z20184003"],"award-info":[{"award-number":["3502Z20184003"]}]},{"name":"Shanghai Municipal Commission of Science and Technology","award":["19441904000"],"award-info":[{"award-number":["19441904000"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk01302"],"award-info":[{"award-number":["shslczdzk01302"]}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Fund","doi-asserted-by":"crossref","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00432-021-03578-7","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T11:03:35Z","timestamp":1620471815000},"page":"3113-3121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"147","author":[{"given":"Zixiang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieakesu","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengzeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9156-2305","authenticated-orcid":false,"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"2","key":"3578_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei W-Q (2018) Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154(2):360\u2013373","journal-title":"Gastroenterology"},{"issue":"2","key":"3578_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/bjc.2011.223","volume":"105","author":"A Algars","year":"2011","unstructured":"Algars A, Lintunen M, Carpen O, Ristamaki R, Sundstrom J (2011) EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer. Br J Cancer 105(2):255\u2013262","journal-title":"Br J Cancer"},{"issue":"12","key":"3578_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A (2018) NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15(12):731\u2013747","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3578_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2015.05.013","volume":"365","author":"L Creancier","year":"2015","unstructured":"Creancier L, Vandenberghe I, Gomes B, Dejean C, Blanchet JC, Meilleroux J et al (2015) Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma. Cancer Lett 365(1):107\u2013111","journal-title":"Cancer Lett"},{"issue":"5","key":"3578_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1440-1746.2006.04074.x","volume":"21","author":"C Dang","year":"2006","unstructured":"Dang C, Zhang Y, Ma Q, Shimahara Y (2006) Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer. J Gastroenterol Hepatol 21(5):850\u2013858","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"3578_CR6","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-11-2906","volume":"18","author":"RC Doebele","year":"2012","unstructured":"Doebele RC, Pilling AB, Aisner DL, Kutateladze TG, Le AT, Weickhardt AJ et al (2012) Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer. Clin Cancer Res 18(5):1472\u20131482","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3578_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1158\/2159-8290.CD-15-0443","volume":"5","author":"RC Doebele","year":"2015","unstructured":"Doebele RC, Davis LE, Vaishnavi A, Le AT, Estrada-Bernal A, Keysar S et al (2015) An Oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the Tropomyosin-related kinase inhibitor LOXO-101. Cancer Discov 5(10):1049\u20131057","journal-title":"Cancer Discov"},{"issue":"8","key":"3578_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD et al (2018) Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med 378(8):731\u2013739","journal-title":"N Engl J Med"},{"issue":"1","key":"3578_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","volume":"32","author":"Z Gatalica","year":"2019","unstructured":"Gatalica Z, Xiu J, Swensen J, Vranic S (2019) Molecular characterization of cancers with NTRK gene fusions. Mod Pathol 32(1):147\u2013153","journal-title":"Mod Pathol"},{"issue":"1","key":"3578_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2009.10.009","volume":"321","author":"A Greco","year":"2010","unstructured":"Greco A, Miranda C, Pierotti MA (2010) Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol Cell Endocrinol 321(1):44\u201349","journal-title":"Mol Cell Endocrinol"},{"key":"3578_CR11","first-page":"18302193","volume":"9","author":"J Huang","year":"2018","unstructured":"Huang J, Song Q, Wang H, Wang H, Xu C, Wang X et al (2018) Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell. Carcinoma 9:18302193","journal-title":"Carcinoma"},{"issue":"3","key":"3578_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0959-4388(00)00092-1","volume":"10","author":"DR Kaplan","year":"2000","unstructured":"Kaplan DR, Miller FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10(3):381\u2013391","journal-title":"Curr Opin Neurobiol"},{"key":"3578_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pharmthera.2017.02.006","volume":"173","author":"YB Khotskaya","year":"2017","unstructured":"Khotskaya YB, Holla VR, Farago AF, Mills Shaw KR, Meric-Bernstam F, Hong DS (2017) Targeting TRK family proteins in cancer. Pharmacol Ther 173:58\u201366","journal-title":"Pharmacol Ther"},{"issue":"3","key":"3578_CR14","doi-asserted-by":"publisher","first-page":"e91940","DOI":"10.1371\/journal.pone.0091940","volume":"9","author":"J Kim","year":"2014","unstructured":"Kim J, Lee Y, Cho HJ, Lee YE, An J, Cho GH et al (2014) NTRK1 fusion in glioblastoma multiforme. PLoS ONE 9(3):e91940","journal-title":"PLoS ONE"},{"issue":"8","key":"3578_CR15","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/PAS.0000000000001070","volume":"42","author":"C Lezcano","year":"2018","unstructured":"Lezcano C, Shoushtari AN, Ariyan C, Hollmann TJ, Busam K (2018) Primary and metastatic melanoma with NTRK fusions. Am J Surg Pathol 42(8):1052\u20131058","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"3578_CR16","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/annonc\/mdq588","volume":"22","author":"L Licitra","year":"2011","unstructured":"Licitra L, Mesia R, Rivera F, Remenar E, Hitt R, Erfan J et al (2011) Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and\/or metastatic squamous cell carcinoma of the head and neck: EXTREME study. Ann Oncol 22(5):1078\u20131087","journal-title":"Ann Oncol"},{"issue":"2","key":"3578_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/pbc.23343","volume":"59","author":"JE Light","year":"2012","unstructured":"Light JE, Koyama H, Minturn JE, Ho R, Simpson AM, Iyer R et al (2012) Clinical significance of NTRK family gene expression in neuroblastomas. Pediatr Blood Cancer 59(2):226\u2013232","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"3578_CR18","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1136\/jclinpath-2018-205124","volume":"71","author":"G Mauri","year":"2018","unstructured":"Mauri G, Valtorta E, Cerea G, Amatu A, Schirru M, Marrapese G et al (2018) TRKA expression and NTRK1 gene copy number across solid tumours. J Clin Pathol 71(10):926\u2013931","journal-title":"J Clin Pathol"},{"issue":"2","key":"3578_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.athoracsur.2018.07.077","volume":"107","author":"TJ Musholt","year":"2019","unstructured":"Musholt TJ, Musholt PB, Khaladj N, Schulz D, Scheumann GF, Klempnauer J (2019) Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyoid carcinoma. Ann Thorac Surg 107(2):436\u2013443","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"3578_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-3835(01)00530-4","volume":"169","author":"A Nakagawara","year":"2001","unstructured":"Nakagawara A (2001) Trk receptor tyrosine kinases_ a bridge between cancer and neural development. Cancer Lett 169(2):107\u2013114","journal-title":"Cancer Lett"},{"issue":"12","key":"3578_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jnci\/djx089","volume":"109","author":"F Pietrantonio","year":"2017","unstructured":"Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Tejpar S, Sartore-Bianchi A et al (2017) ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer. J Natl Cancer Inst 109(12):9","journal-title":"J Natl Cancer Inst"},{"issue":"26","key":"3578_CR22","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMra1314530","volume":"371","author":"AK Rustgi","year":"2014","unstructured":"Rustgi AK, El-Serag HB (2014) Esophageal carcinoma. N Engl J Med 371(26):2499\u20132509","journal-title":"N Engl J Med"},{"issue":"5","key":"3578_CR23","first-page":"264","volume":"15","author":"P Sidaway","year":"2018","unstructured":"Sidaway P (2018) Targeted therapy: Larotrectinib effective against TRK-fusion-positive cancers. Nat Rev Clin Oncol 15(5):264","journal-title":"Nat Rev Clin Oncol"},{"key":"3578_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-319-91830-3_2","volume":"2","author":"D Tong","year":"2018","unstructured":"Tong D, Law S (2018) Esophageal squamous cell cancer: pathogenesis and epidemiology. Esophageal Cancer 2:15\u201320","journal-title":"Esophageal Cancer"},{"issue":"11","key":"3578_CR25","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/nm.3352","volume":"19","author":"A Vaishnavi","year":"2013","unstructured":"Vaishnavi A, Capelletti M, Le AT, Kako S, Butaney M, Ercan D et al (2013) Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med 19(11):1469\u20131472","journal-title":"Nat Med"},{"issue":"1","key":"3578_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1158\/2159-8290.CD-14-0765","volume":"5","author":"A Vaishnavi","year":"2015","unstructured":"Vaishnavi A, Le AT, Doebele RC (2015) TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov 5(1):25\u201334","journal-title":"Cancer Discov"},{"issue":"2","key":"3578_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0888-7543(95)80226-C","volume":"26","author":"HU Weier","year":"1995","unstructured":"Weier HU, Rhein AP, Shadravan F, Collins C, Polikoff D (1995) Rapid physical mapping of the human trk protooncogene (NTRK1) to human chromosome 1q21-q22 by P1 clone selection, fluorescence in situ hybridization (FISH), and computer-assisted microscopy. Genomics 26(2):390\u2013393","journal-title":"Genomics"},{"issue":"1","key":"3578_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1746-1596-8-9","volume":"8","author":"S Yuan","year":"2013","unstructured":"Yuan S, Hou He, Yingyong Hu et al (2013) An alternative high output tissue microarray technique. Diagnostic Pathol 8(1):9\u201347","journal-title":"Diagnostic Pathol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03578-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T19:20:03Z","timestamp":1672082403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03578-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03578-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"14 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Ethics Committee of Zhongshan Hospital of Fudan University (Shanghai, China). Our study was in accordance with the Declaration of Helsinki 1975 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from patients for use of their surgical specimens for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}